Earnings Call Insights: Mind Medicine (MindMed) Inc. (MNMD) Q3 2025 CEO Robert Barrow stated, "We delivered another solid quarter, advancing our clinical programs and continuing to build one of the ...
NEW YORK--(BUSINESS WIRE)--Researchers from Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results